No black box warning on record for Trandolapril

As of the latest FDA labeling reviewed, Trandolapril (TRANDOLAPRIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Trandolapril medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors, including trandolapril, may be subject to a variety of adverse reactions, some of them serious. Anaphylactoid Reactions During Desensitization Two patients undergo

No black box warning on record for Trandolapril

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors, including trandolapril, may be subject to a variety of adverse reactions, some of them serious. Anaphylactoid Reactions During Desensitization Two patients undergo

Trandolapril Black Box Warning

No black box warning on record for Trandolapril

Other warnings & precautions

Trandolapril Black Box Warning

No black box warning on record for Trandolapril

Other warnings & precautions